Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2024 Earnings Call Transcript February 7, 2025
Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.24.
Operator: Hello, everyone. And welcome to the Iterum Therapeutics plc Fourth Quarter and Full Year 2024 financial results. My name is Ezra, and I will be your coordinator today [Operator Instructions]. I will now hand you over to Louise Barrett, Senior Vice President, Legal Affairs, to begin. Louise,...
